UY26492A1 - BENCIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES. - Google Patents

BENCIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES.

Info

Publication number
UY26492A1
UY26492A1 UY26492A UY26492A UY26492A1 UY 26492 A1 UY26492 A1 UY 26492A1 UY 26492 A UY26492 A UY 26492A UY 26492 A UY26492 A UY 26492A UY 26492 A1 UY26492 A1 UY 26492A1
Authority
UY
Uruguay
Prior art keywords
bencimidazoles
medicines
preparation
tautomers
stereoisomers
Prior art date
Application number
UY26492A
Other languages
Spanish (es)
Inventor
Dr Uwe Ries
Dr Iris Kauffmann-Hefner
Dr Henning Priepke
Dr Herbert Nar
Dr Jean Marie Stassen
Dr Wolfgang Wienen
Dr Norbert Hauel
Original Assignee
Boehringer Ingelheim Pharma
Amp
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Amp, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY26492A1 publication Critical patent/UY26492A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos bencimidazoles de la fórmula general (I) sus tautómeros, sus estereoisómeros, sus mezclas, sus pro fármacos, sus derivados que, en lugar de un grupo carboxi, contiene un grupo cargado negativamente en condiciones fisiológicamente compatibles, con ácidos o bases inorgánicas u orgánicos, que presentan valiosas propiedades.The present invention relates to new benzimidazoles of the general formula (I), their tautomers, their stereoisomers, their mixtures, their pro-drugs, their derivatives which, instead of a carboxy group, contains a negatively charged group under physiologically compatible conditions, with inorganic or organic acids or bases, which have valuable properties.

UY26492A 1999-12-23 2000-12-20 BENCIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES. UY26492A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19962329A DE19962329A1 (en) 1999-12-23 1999-12-23 New substituted 2-(phenylaminomethyl)-benzimidazoles, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates

Publications (1)

Publication Number Publication Date
UY26492A1 true UY26492A1 (en) 2001-07-31

Family

ID=7934028

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26492A UY26492A1 (en) 1999-12-23 2000-12-20 BENCIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES.

Country Status (10)

Country Link
EP (1) EP1244636A1 (en)
JP (1) JP2003519129A (en)
AR (1) AR027050A1 (en)
AU (1) AU2011501A (en)
CA (1) CA2393916A1 (en)
DE (1) DE19962329A1 (en)
MX (1) MXPA02006299A (en)
PE (1) PE20010954A1 (en)
UY (1) UY26492A1 (en)
WO (1) WO2001047896A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125478A1 (en) * 2001-05-25 2002-11-28 Boehringer Ingelheim Pharma Treatment or prophylaxis of arterial thrombosis, using 5-quinolinesulfonylamino-benzimidazole derivatives having combined thrombin inhibiting and fibrinogen receptor inhibiting action
DE10227666A1 (en) * 2002-06-20 2004-01-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg (R) -2- (4-amidinophenylaminomethyl) -1-methyl-5- [1- (carboxymethylamino) -1- (pyrrolidinocarbonyl) ethyl] benzimidazole, its monohydrochloride, process for its preparation and use as a medicament
US7169934B2 (en) 2002-06-20 2007-01-30 Boehringer Ingelheim International Gmbh (R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition
PE20040804A1 (en) 2002-12-19 2004-12-31 Boehringer Ingelheim Pharma CARBOXAMID DERIVATIVES AS INHIBITORS OF THE Xa FACTOR
US7371743B2 (en) 2004-02-28 2008-05-13 Boehringer Ingelheim International Gmbh Carboxylic acid amides, the preparation thereof and their use as medicaments
EP1609784A1 (en) * 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Process for the preparation of 4-(benzimidazolylmethylamino)-benzamidines
DE102005061623A1 (en) 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Improved process for the preparation of 4- (benzimidazolylmethylamino) -benzamidines and their salts
DE102005061624A1 (en) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Improved process for the preparation of salts of 4- (benzimidazolylmethylamino) -benzamidines
US9533971B2 (en) 2012-10-29 2017-01-03 Biophore India Pharmaceuticals Pvt. Ltd Process for the synthesis of dabigatran and its intermediates
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
RU2623439C1 (en) * 2016-10-14 2017-06-26 федеральное государственное автономное образовательное учреждение высшего образования "Южный федеральный университет" 1-substituted-3-{[2-(3,5-di-tret-4-hydroxyphenyl)-2-oxoethyl]}-2aminobenzimidazolium bromides with antiplatelet and antioxidant properties

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129603A1 (en) * 1991-09-06 1993-03-11 Thomae Gmbh Dr K CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS
WO1999040072A1 (en) * 1998-02-03 1999-08-12 Boehringer Ingelheim Pharma Kg Five-membered, benzo-condensed heterocycles used as antithrombotic agents
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
DE19829964A1 (en) * 1998-07-04 2000-01-05 Boehringer Ingelheim Pharma New benzimidazolyl amidine or nitrile compounds, used as thrombin inhibitors, antithrombotic agents or intermediates

Also Published As

Publication number Publication date
WO2001047896A1 (en) 2001-07-05
MXPA02006299A (en) 2002-12-09
AU2011501A (en) 2001-07-09
CA2393916A1 (en) 2001-07-05
PE20010954A1 (en) 2001-10-09
EP1244636A1 (en) 2002-10-02
JP2003519129A (en) 2003-06-17
DE19962329A1 (en) 2001-06-28
AR027050A1 (en) 2003-03-12

Similar Documents

Publication Publication Date Title
UY26066A1 (en) BICYCLE HETERO CYCLES, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURES FOR THEIR PREPARATION
UY27078A1 (en) DERIVATIVES OF QUINAZOLINE, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION
UY26903A1 (en) BICYCLIC HETEROCICLES, DRUGS CONTAINING THESE COMPOUNDS, THEIR EMPLOYMENT AND PROCEDURES FOR THEIR PREPARATION
UY26513A1 (en) NEW REPLACED PIPERIDINES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
ECSP034688A (en) DERIVATIVES OF XANTINA, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS
ECSP088824A (en) Substituted prolinamides, their preparation and their use as medicines
UY28103A1 (en) NEW IMIDAZO-PIRIDINONAS REPLACED, ITS PREPARATION AND ITS EMPLOYMENT AS MEDICATIONS
MX9305566A (en) DERIVATIVES OF UREA CYCLICS, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
ECSP034924A (en) Substituted derivatives of 1-oxa-2,8-daza-spiro [4,5] dec-2-eno
SV1999000118A (en) NEW SUBSTITUTED PIRAZOL DERIVATIVES REF. READ 33188-SV
UY30979A1 (en) REPLACED PIRROLIDINAMIDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
BR0010215A (en) Indoline derivatives as progesterone antagonists
UY26492A1 (en) BENCIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS MEDICINES.
CL2003002665A1 (en) COMPOUNDS DERIVED FROM CARBOXILIC ACIDS, ITS SALTS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION, AND ITS USE IN THE TREATMENT OF DISEASES WHERE AN INHIBITOR OF THE FACTOR Xa AND / OR AN INHIBITOR OF SERINA PROTEASA IS NECESSARY.
MX9303466A (en) DERIVATIVES OF BIPHENYL, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
UY26067A1 (en) BICYCLE HETERO CYCLES, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCEDURE
BR0007229A (en) Substituted heterocyclic aminoazacycles useful as central nervous system agents
ECSP109978A (en) New compounds
UY26133A1 (en) SUBSTITUTED DERIVATIVE OF PYRAZOLE.
AR040763A1 (en) PROFARMACOS OF THE (N-2- PIRIDIL-N-2- HYDROXICARBONIL-ETIL) - AMID OF THE ACID 1- METHYL-2- (4-AMIDINOPHENYLAMINOMETIL) - BENZIMIDAZOL-5-IL-CARBOXILICO, ITS PREPARATION AND ITS USE AS MEDICATIONS
BRPI0412843A (en) substituted lactams and their use as anticancer agents
MX9302459A (en) IMINO CYCLE DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
DE50105075D1 (en) An oxidation
EA200970497A1 (en) PYRROLA DERIVATIVES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
MXPA03008250A (en) Novel diaminopyrazole derivatives and dyes containing said compounds.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20121105